文献速递肝病

2019年全球非酒精性脂肪性肝病患病率:系统综述与荟萃分析

2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-12-07

该系统综述与荟萃分析检索截至2020年3月26日的文献,纳入245项研究、5,399,254名个体,全球非酒精性脂肪性肝病(NAFLD)合并患病率为29.8%(95%CI 28.6%-31.1%);1991年至2019年患病率从21.9%升至37.3%,每年增加0.7%(P < .0001)。

要点

  • 全球NAFLD合并患病率为29.8%(95%CI 28.6%-31.1%)。
  • 1991年至2019年NAFLD患病率从21.9%升至37.3%,每年增加0.7%(P < .0001)。
  • 南美洲年变化最快为2.7%,其次欧洲为1.1%。

核心结论

  • 尽管存在地区差异,全球NAFLD患病率总体呈上升趋势。
  • 政策制定者必须通过提高对NAFLD的认识和促进健康生活方式环境来扭转当前趋势。

研究设计与样本

  • 系统检索从建库至2020年3月26日,无语言限制。
  • 两位作者独立进行筛选和数据提取。
  • 采用荟萃回归分析NAFLD患病率趋势。
  • 共纳入245项符合条件的研究,涉及5,399,254名个体。

主要发现

  • 全球NAFLD合并患病率为29.8%(95%CI 28.6%-31.1%)。
  • 82.5%的纳入文章使用超声诊断NAFLD,其患病率为30.6%(95%CI 29.2%-32.0%)。
  • 南美洲(3项研究,5,716名个体)NAFLD患病率最高,为35.7%(95%CI 34.0%-37.5%)。
  • 北美洲(4项研究,18,236名个体)NAFLD患病率为35.3%(95%CI 25.4%-45.9%)。
  • 1991年至2019年,NAFLD患病率从21.9%升至37.3%(每年增加0.7%,P < .0001),南美洲年变化最快为2.7%,其次欧洲为1.1%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The increasing rates of obesity and type 2 diabetes mellitus may lead to increased prevalence of nonalcoholic fatty liver disease (NAFLD). We aimed to determine the current and recent trends on the global and regional prevalence of NAFLD. METHODS: Systematic search from inception to March 26, 2020 was performed without language restrictions. Two authors independently performed screening and data extraction. We performed meta-regression to determine trends in NAFLD prevalence. RESULTS: We identified 17,244 articles from literature search and included 245 eligible studies involving 5,399,254 individuals. The pooled global prevalence of NAFLD was 29.8% (95% confidence interval [CI], 28.6%-31.1%); of these, 82.5% of included articles used ultrasound to diagnose NAFLD, with prevalence of 30.6% (95% CI, 29.2%-32.0%). South America (3 studies, 5716 individuals) and North America (4 studies, 18,236 individuals) had the highest NAFLD prevalence at 35.7% (95% CI, 34.0%-37.5%) and 35.3% (95% CI, 25.4%-45.9%), respectively. From 1991 to 2019, trend analysis showed NAFLD increased from 21.9% to 37.3% (yearly increase of 0.7%, P < .0001), with South America showing the most rapid change of 2.7% per year, followed by Europe at 1.1%. CONCLUSIONS: Despite regional variation, the global prevalence of NAFLD is increasing overall. Policy makers must work toward reversing the current trends by increasing awareness of NAFLD and promoting healthy lifestyle environments.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Le MH, Yeo YH, Li X, et al. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021. PMID: 34890795. doi:10.1016/j.cgh.2021.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。